Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 308

Similar articles for PubMed (Select 21956196)

1.

Direct renin inhibition in a rat model of chronic allograft injury.

Rusai K, Schmaderer C, Hermans JJ, Lutz J, Heemann U, Baumann M.

Transplantation. 2011 Nov 15;92(9):999-1004. doi: 10.1097/TP.0b013e318230c05b.

PMID:
21956196
2.

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.

Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC.

Kidney Int. 2005 Nov;68(5):2189-96.

PMID:
16221218
3.

Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.

Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM.

Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2166-72. Epub 2006 Jun 9.

4.

Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.

Moniwa N, Varagic J, Ahmad S, VonCannon JL, Simington SW, Wang H, Groban L, Brosnihan KB, Nagata S, Kato J, Kitamura K, Gomez RA, Lopez ML, Ferrario CM.

Hypertension. 2013 Feb;61(2):417-24. doi: 10.1161/HYPERTENSIONAHA.112.201889. Epub 2012 Dec 10.

5.

Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.

Moniwa N, Varagic J, Ahmad S, VonCannon JL, Ferrario CM.

Ther Adv Cardiovasc Dis. 2012 Feb;6(1):15-29. doi: 10.1177/1753944711434039. Epub 2012 Jan 5.

6.

Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.

Varagic J, Ahmad S, VonCannon JL, Moniwa N, Brosnihan KB, Wysocki J, Batlle D, Ferrario CM.

Am J Hypertens. 2013 May;26(5):583-90. doi: 10.1093/ajh/hps090. Epub 2013 Mar 4.

7.

Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.

Sakoda M, Ichihara A, Kurauchi-Mito A, Narita T, Kinouchi K, Murohashi-Bokuda K, Saleem MA, Nishiyama A, Suzuki F, Itoh H.

Am J Hypertens. 2010 May;23(5):575-80. doi: 10.1038/ajh.2009.273. Epub 2010 Jan 14.

PMID:
20075844
8.

Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Whaley-Connell A, Nistala R, Habibi J, Hayden MR, Schneider RI, Johnson MS, Tilmon R, Rehmer N, Ferrario CM, Sowers JR.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F655-61. doi: 10.1152/ajprenal.00373.2009. Epub 2009 Dec 9.

9.

[The future of renin inhibition].

Uresin AY, Baran E.

Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:32-8. Turkish.

PMID:
20019475
10.

Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats.

Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1327-33. Epub 2007 Jul 6.

11.

Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.

Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F.

Kidney Int. 1999 Mar;55(3):877-89.

12.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
13.

Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.

Whaley-Connell A, Habibi J, Nistala R, Hayden MR, Pulakat L, Sinak C, Locher B, Ferrario CM, Sowers JR.

Regul Pept. 2012 Jun 10;176(1-3):36-44. doi: 10.1016/j.regpep.2012.03.002. Epub 2012 Mar 29.

14.

Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.

Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM.

J Hypertens Suppl. 1997 Dec;15(6):S21-5.

PMID:
9493123
15.

Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production.

Singh VP, Baker KM, Kumar R.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1675-84. doi: 10.1152/ajpheart.91493.2007. Epub 2008 Feb 22.

16.

AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.

Fraune C, Lange S, Krebs C, Hölzel A, Baucke J, Divac N, Schwedhelm E, Streichert T, Velden J, Garrelds IM, Danser AH, Frenay AR, van Goor H, Jankowski V, Stahl R, Nguyen G, Wenzel UO.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1037-48. doi: 10.1152/ajprenal.00672.2011. Epub 2012 Jul 11.

18.

Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.

Sepehrdad R, Frishman WH, Stier CT Jr, Sica DA.

Cardiol Rev. 2007 Sep-Oct;15(5):242-56. Review.

PMID:
17700383
19.
20.

Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.

Nagata S, Kato J, Kuwasako K, Asami M, Kitamura K.

Hypertens Res. 2012 Feb;35(2):234-8. doi: 10.1038/hr.2011.165. Epub 2011 Oct 13.

PMID:
21993212
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk